Tuberculosis vaccines: Progress and challenges

Tuberculosis vaccines: Progress and challenges

Čájet eará veršuvnnaid (1)

An effective tuberculosis (TB) vaccine could have a significant impact on the current TB pandemic. The past decade has seen sustained global investment into reaching this goal; currently there are several promising vaccines in clinical trials. Current strategies include the development of an improve...

Bibliográfalaš dieđut
Váldodahkkit:	Checkley, A, McShane, H
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2011

Geahča maid

Tuberculosis vaccines: progress and challenges.
Dahkki: Checkley, A, et al.
Almmustuhtton: (2011)

Insights and challenges in tuberculosis vaccine development
Dahkki: McShane, H
Almmustuhtton: (2019)

Vaccines for tuberculosis
Dahkki: McShane, H
Almmustuhtton: (2013)

Vaccine strategies against tuberculosis
Dahkki: H McShane
Almmustuhtton: (2009-03-01)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
Dahkki: McShane, H
Almmustuhtton: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
Dahkki: McShane, H
Almmustuhtton: (2011)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
Dahkki: Morrison, H, et al.
Almmustuhtton: (2023)

Challenges in developing a controlled human tuberculosis challenge model
Dahkki: Jackson, S, et al.
Almmustuhtton: (2022)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
Dahkki: Stylianou, E, et al.
Almmustuhtton: (2019)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
Dahkki: McShane, H
Almmustuhtton: (2023)

Progress and challenges in TB vaccine development
Dahkki: Voss, G, et al.
Almmustuhtton: (2018)

Why don’t we have an effective tuberculosis vaccine yet?
Dahkki: Davenne, T, et al.
Almmustuhtton: (2016)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
Dahkki: Hazel Morrison, et al.
Almmustuhtton: (2023-05-01)

Clinical testing of tuberculosis vaccine candidates
Dahkki: Hatherill, M, et al.
Almmustuhtton: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
Dahkki: Vermaak, S, et al.
Almmustuhtton: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
Dahkki: Tanner, R, et al.
Almmustuhtton: (2016)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
Dahkki: Griffiths, K, et al.
Almmustuhtton: (2013)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
Dahkki: Dockrell, HM, et al.
Almmustuhtton: (2022)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
Dahkki: Fletcher, H, et al.
Almmustuhtton: (2009)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
Dahkki: Poyntz, H, et al.
Almmustuhtton: (2014)

Human and Bovine Tuberculosis
Dahkki: McShane, H
Almmustuhtton: (2016)

Vaccination against tuberculosis: how can we better BCG?
Dahkki: Pitt, J, et al.
Almmustuhtton: (2013)

Vaccination against tuberculosis: How can we better BCG?
Dahkki: Pitt, J, et al.
Almmustuhtton: (2013)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
Dahkki: Villarreal-Ramos, B, et al.
Almmustuhtton: (2017)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
Dahkki: Hazel M. Dockrell, et al.
Almmustuhtton: (2022-05-01)

Vaccine strategies against tuberculosis.
Dahkki: Mcshane, H
Almmustuhtton: (2009)

Exploring the ethics of tuberculosis human challenge models
Dahkki: Rohrig, A, et al.
Almmustuhtton: (2023)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Dahkki: Hopkins, R, et al.
Almmustuhtton: (2011)

Tuberculosis vaccines: present and future.
Dahkki: Minassian, A, et al.
Almmustuhtton: (2008)

Progress and challenges in TB vaccine development [version 1; referees: 2 approved]
Dahkki: Gerald Voss, et al.
Almmustuhtton: (2018-02-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
Dahkki: McShane, H
Almmustuhtton: (2020)

Developing an improved vaccine against tuberculosis.
Dahkki: Mcshane, H
Almmustuhtton: (2004)

Local pulmonary immunological biomarkers in tuberculosis
Dahkki: Morrison, H, et al.
Almmustuhtton: (2021)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
Dahkki: Mcshane, H, et al.
Almmustuhtton: (2016)

Tuberculosis vaccines in clinical trials.
Dahkki: Rowland, R, et al.
Almmustuhtton: (2011)

Tuberculosis vaccine promises sterilizing immunity.
Dahkki: Mcshane, H, et al.
Almmustuhtton: (2011)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
Dahkki: Griffiths, K, et al.
Almmustuhtton: (2011)

Vaccines
Dahkki: Minhinnick, A, et al.
Almmustuhtton: (2014)

Tuberculosis vaccines: current status and future prospects.
Dahkki: Fletcher, H, et al.
Almmustuhtton: (2006)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
Dahkki: Minassian, A, et al.
Almmustuhtton: (2011)